EASTER

ESTrogen and Stents to Eliminate Restenosis. A very small (30 patients) trial evaluating the feasibility and safety of 17-estradiol-eluting stent for treating single native vessel stenosis
Primary endpoints MACE, death, MI, TLR, stent thrombosis at 1 and 6 months
Conclusion 17-beta-estradiol-eluted stents appear feasible and safe, showing low rates of binary restenosis and revascularization. These results warrant further confirmation with a large, randomized multicenter trial